Related references
Note: Only part of the references are listed.On the Calculation of TCID50 for Quantitation of Virus Infectivity
Chengfeng Lei et al.
VIROLOGICA SINICA (2021)
Analysis of homologous and heterologous interactions between UDP-galactose transporter and beta-1,4-galactosyltransferase 1 using NanoBiT
Wojciech Wiertelak et al.
ANALYTICAL BIOCHEMISTRY (2020)
Vpu modulates DNA repair to suppress innate sensing and hyper-integration of HIV-1
Meta Volcic et al.
NATURE MICROBIOLOGY (2020)
NanoLuc Complementation Reporter Optimized for Accurate Measurement of Protein Interactions in Cells
Andrew S. Dixon et al.
ACS CHEMICAL BIOLOGY (2016)
HIV-1 Vpu Mediates HLA-C Downregulation
Richard Apps et al.
CELL HOST & MICROBE (2016)
Novel Acylguanidine-Based Inhibitor of HIV-1
Philip Mwimanzi et al.
JOURNAL OF VIROLOGY (2016)
2-thio-6-azauridine inhibits Vpu mediated BST-2 degradation
Quan Zhang et al.
RETROVIROLOGY (2016)
Ion Channel Activity of Vpu Proteins Is Conserved throughout Evolution of HIV-1 and SIV
Timo Greiner et al.
VIRUSES-BASEL (2016)
Cell Surface Proteomic Map of HIV Infection Reveals Antagonism of Amino Acid Metabolism by Vpu and Nef
Nicholas J. Matheson et al.
CELL HOST & MICROBE (2015)
A small molecule compound IMB-LA inhibits HIV-1 infection by preventing viral Vpu from antagonizing the host restriction factor BST-2
Zeyun Mi et al.
SCIENTIFIC REPORTS (2015)
Vpu Exploits the Cross-Talk between BST2 and the ILT7 Receptor to Suppress Anti-HIV-1 Responses by Plasmacytoid Dendritic Cells
Mariana G. Bego et al.
PLOS PATHOGENS (2015)
Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1
Marcella Sarzotti-Kelsoe et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2014)
HIV-1 Vpu Antagonism of Tetherin Inhibits Antibody-Dependent Cellular Cytotoxic Responses by Natural Killer Cells
Raymond A. Alvarez et al.
JOURNAL OF VIROLOGY (2014)
Counteraction of the multifunctional restriction factor tetherin
Daniel Sauter
FRONTIERS IN MICROBIOLOGY (2014)
Y-39983, a Selective Rho-Kinase Inhibitor, Attenuates Experimental Autoimmune Encephalomyelitis via Inhibition of Demyelination
Cong Gao et al.
NEUROIMMUNOMODULATION (2013)
Identification of novel key amino acids at the interface of the transmembrane domains of human BST-2 and HIV-1 Vpu
Xiaojing Pang et al.
RETROVIROLOGY (2013)
Mechanism of HIV-1 Virion Entrapment by Tetherin
Siddarth Venkatesh et al.
PLOS PATHOGENS (2013)
Development and implementation of an international proficiency testing program for a neutralizing antibody assay for HIV-1 in TZM-bl cells
Christopher A. Todd et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2012)
Transmembrane Domain Determinants of CD4 Downregulation by HIV-1 Vpu
Javier G. Magadan et al.
JOURNAL OF VIROLOGY (2012)
Epidemiology and immunology of helminth-HIV interactions
Emily L. Webb et al.
CURRENT OPINION IN HIV AND AIDS (2012)
High-throughput assay to identify inhibitors of Vpu-mediated down-regulation of cell surface BST-2
Quan Zhang et al.
ANTIVIRAL RESEARCH (2011)
Identification of Amino Acids in the Human Tetherin Transmembrane Domain Responsible for HIV-1 Vpu Interaction and Susceptibility
Tomoko Kobayashi et al.
JOURNAL OF VIROLOGY (2011)
Differential Effects of Human Immunodeficiency Virus Type 1 Vpu on the Stability of BST-2/Tetherin
Amy J. Andrew et al.
JOURNAL OF VIROLOGY (2011)
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
Myron S. Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
HIV-1 Vpu Antagonizes BST-2 by Interfering Mainly with the Trafficking of Newly Synthesized BST-2 to the Cell Surface
Mathieu Dube et al.
TRAFFIC (2011)
BST-2 is rapidly down-regulated from the cell surface by the HIV-1 protein Vpu: Evidence for a post-ER mechanism of Vpu-action
Mark Skasko et al.
VIROLOGY (2011)
HIV-1 Vpu Blocks Recycling and Biosynthetic Transport of the Intrinsic Immunity Factor CD317/Tetherin To Overcome the Virion Release Restriction
Sarah Schmidt et al.
MBIO (2011)
Inhibition of lipid antigen presentation in dendritic cells by HIV-1 Vpu interference with CD1d recycling from endosomal compartments
Markus Moll et al.
BLOOD (2010)
Degranulation of Natural Killer Cells Following Interaction with HIV-1-Infected Cells Is Hindered by Downmodulation of NTB-A by Vpu
Ankur H. Shah et al.
CELL HOST & MICROBE (2010)
Twenty-Six Years of Anti-HIV Drug Discovery: Where Do We Stand and Where Do We Go?
Youcef Mehellou et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Antagonism of Tetherin Restriction of HIV-1 Release by Vpu Involves Binding and Sequestration of the Restriction Factor in a Perinuclear Compartment
Mathieu Dube et al.
PLOS PATHOGENS (2010)
HIV-1 Accessory Protein Vpu Internalizes Cell-surface BST-2/Tetherin through Transmembrane Interactions Leading to Lysosomes
Yukie Iwabu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Broad-Spectrum Inhibition of Retroviral and Filoviral Particle Release by Tetherin
Nolwenn Jouvenet et al.
JOURNAL OF VIROLOGY (2009)
Vpu Directs the Degradation of the Human Immunodeficiency Virus Restriction Factor BST-2/Tetherin via a βTrCP-Dependent Mechanism
Janet L. Douglas et al.
JOURNAL OF VIROLOGY (2009)
The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein
Nanette Van Damme et al.
CELL HOST & MICROBE (2008)
The ties that bind a virus to the cell
Robert P. Kruger
CELL (2008)
Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu
Stuart J. D. Neil et al.
NATURE (2008)
Combination assay detecting both human immunodeficiency virus (HIV) p24 antigen and anti-HIV antibodies opens a second diagnostic window
D Speers et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection
EW Fiebig et al.
AIDS (2003)
Share Paper
